Treatment of trastuzumab-refractory, HER2-positive metastatic breast cancer

Clin Adv Hematol Oncol. 2014 Apr;12(4):260-2.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Drug Resistance, Neoplasm / drug effects*
  • Drug Resistance, Neoplasm / physiology
  • Female
  • Humans
  • Neoplasm Metastasis
  • Receptor, ErbB-2 / biosynthesis*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptor, ErbB-2
  • Trastuzumab